Clinical Trials Directory

Trials / Unknown

UnknownNCT05554185

Probiotic Supplementation During Pregnancy in Preeclampsia High-risk Groups

Effects of Probiotic Supplementation During Pregnancy on Maternal and Infant Outcomes in Preeclampsia High-risk Groups Based on Abnormal Intestinal Flora: a Randomized Controlled Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
338 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

In this randomized controlled study, preventive intervention of aspirin combined with probiotics or aspirin combined with placebo would given to PE (pre-eclampsia) high-risk population with gut microbiota dysbiosis during their pregnancy, and finally assess the efficacy and safety of aspirin combined with probiotics to prevent PE.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTaspirin 100mg and probiotics 1 bagtaking aspirin 100mg and probiotics 1 bag per day from 14-16 weeks of pregnancy until 35 + 6 weeks of pregnancy or emergency delivery.

Timeline

Start date
2022-09-21
Primary completion
2023-12-31
Completion
2024-12-31
First posted
2022-09-26
Last updated
2022-09-26

Source: ClinicalTrials.gov record NCT05554185. Inclusion in this directory is not an endorsement.